Smith, Moore & Co. Becton Dickinson & CO Transaction History

Smith, Moore & Co.

$935 Million
Q1 2024

A detailed history of Smith, Moore & Co. transactions in Becton Dickinson & CO stock. As of the latest transaction made, Smith, Moore & Co. holds 1,679 shares of BDX stock, worth $384,893. This represents 0.04% of its overall portfolio holdings.

Number of Shares

1,679

Previous 1,680 0.06%

Holding current value

$384,893

Previous $409,000 1.47%

% of portfolio

0.04%

Previous 0.05%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$233.45 - $247.73 $233 - $247	-1 Reduced 0.06%	1,679 $415,000
Q4 2023 Feb 13, 2024	SELL	$232.24 - $267.23 $31,584 - $36,343	-136 Reduced 7.49%	1,680 $409,000
Q3 2023 Nov 14, 2023	BUY	$254.9 - $283.59 $254 - $283	1 Added 0.06%	1,816 $469,000
Q2 2023 Aug 11, 2023	SELL	$238.39 - $265.32 $3,814 - $4,245	-16 Reduced 0.87%	1,815 $479,000
Q1 2023 May 12, 2023	BUY	$229.71 - $259.35 $229 - $259	1 Added 0.05%	1,831 $453,000

Q4 2022 Feb 13, 2023	BUY	$218.29 - $256.91 $218 - $256	1 Added 0.05%	1,830 $465,000
Q3 2022 Nov 14, 2022	BUY	$51.03 - $264.23 $51 - $264	1 Added 0.05%	1,829 $407,000
Q2 2022 Aug 12, 2022	BUY	$234.74 - $275.42 $1,173 - $1,377	5 Added 0.27%	1,828 $451,000
Q1 2022 May 12, 2022	SELL	$243.64 - $270.48 $6,821 - $7,573	-28 Reduced 1.51%	1,823 $485,000
Q4 2021 Feb 08, 2022	SELL	$230.08 - $250.94 $3,221 - $3,513	-14 Reduced 0.75%	1,851 $466,000
Q3 2021 Nov 12, 2021	SELL	$232.72 - $256.47 $11,403 - $12,567	-49 Reduced 2.56%	1,865 $458,000
Q2 2021 Aug 10, 2021	SELL	$232.65 - $254.58 $47,460 - $51,934	-204 Reduced 9.63%	1,914 $466,000
Q1 2021 May 14, 2021	SELL	$232.09 - $256.88 $25,529 - $28,256	-110 Reduced 4.94%	2,118 $515,000
Q4 2020 Feb 16, 2021	SELL	$221.92 - $245.94 $101,417 - $112,394	-457 Reduced 17.02%	2,228 $558,000
Q3 2020 Nov 12, 2020	SELL	$215.77 - $276.76 $53,726 - $68,913	-249 Reduced 8.49%	2,685 $625,000
Q2 2020 Aug 10, 2020	BUY	$219.9 - $263.41 $397,139 - $475,718	1,806 Added 160.11%	2,934 $702,000
Q1 2020 May 15, 2020	BUY	$195.69 - $279.01 $35,615 - $50,779	182 Added 19.24%	1,128 $259,000
Q4 2019 Feb 07, 2020	BUY	$236.45 - $266.82 $236 - $266	1 Added 0.11%	946 $257,000
Q3 2019 Nov 07, 2019	SELL	$230.58 - $256.08 $80,703 - $89,628	-350 Reduced 27.03%	945 $239,000
Q2 2019 Aug 15, 2019	BUY	$217.4 - $246.08 $13,261 - $15,010	61 Added 4.94%	1,295 $326,000
Q1 2019 May 07, 2019	SELL	$206.05 - $248.17 $403,651 - $486,165	-1,959 Reduced 61.35%	1,234 $308,000
Q4 2018 Feb 15, 2019	SELL	$204.73 - $257.93 $8,189 - $10,317	-40 Reduced 1.24%	3,193 $720,000
Q3 2018 Nov 15, 2018	BUY	$233.07 - $256.0 $21,908 - $24,064	94 Added 2.99%	3,233 $844,000
Q2 2018 Aug 14, 2018	SELL	$208.1 - $233.85 $7,907 - $8,886	-38 Reduced 1.2%	3,139 $752,000
Q1 2018 May 14, 2018	BUY	$205.46 - $240.27 $263,194 - $307,785	1,281 Added 67.56%	3,177 $689,000
Q4 2017 Feb 09, 2018	SELL	$189.0 - $222.64 $16,254 - $19,147	-86 Reduced 4.34%	1,896 $406,000
Q3 2017 Nov 02, 2017	BUY	$186.89 - $198.9 $370,415 - $394,219	1,982	1,982 $388,000

Others Institutions Holding BDX

# of Institutions

1,730

Shares Held

240M

Call Options Held

640K

Put Options Held

766K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $65.4B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Smith, Moore & Co., based on Form 13F filings with the SEC.

News

Stay updated on Smith, Moore & Co. with notifications on news.

Account